Vanguard Group Inc Medpace Holdings, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,282,972 shares of MEDP stock, worth $1.35 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,282,972
Previous 2,390,623 4.5%
Holding current value
$1.35 Billion
Previous $750 Million 56.44%
% of portfolio
0.02%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$308.88 - $514.16 $33.3 Million - $55.3 Million
-107,651 Reduced 4.5%
2,282,972 $1.17 Billion
Q2 2025

Aug 11, 2025
SELL
$277.23 - $315.28 $39.6 Million - $45.1 Million
-142,983 Reduced 5.64%
2,390,623 $750 Million
Q1 2025

May 09, 2025
SELL
$304.69 - $360.97 $11.3 Million - $13.4 Million
-37,164 Reduced 1.45%
2,533,606 $772 Million
Q4 2024

Feb 11, 2025
BUY
$308.93 - $363.58 $7.94 Million - $9.35 Million
25,704 Added 1.01%
2,570,770 $854 Million
Q3 2024

Nov 13, 2024
BUY
$320.58 - $457.29 $5.55 Million - $7.92 Million
17,309 Added 0.68%
2,545,066 $849 Million
Q2 2024

Aug 13, 2024
BUY
$372.0 - $424.34 $8.72 Million - $9.95 Million
23,443 Added 0.94%
2,527,757 $1.04 Billion
Q1 2024

May 10, 2024
SELL
$284.87 - $413.31 $14.8 Million - $21.5 Million
-52,129 Reduced 2.04%
2,504,314 $1.01 Billion
Q4 2023

Feb 14, 2024
BUY
$227.52 - $312.68 $32.4 Million - $44.6 Million
142,591 Added 5.91%
2,556,443 $784 Million
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $11.3 Million - $13.6 Million
-48,331 Reduced 1.96%
2,413,852 $584 Million
Q2 2023

Aug 14, 2023
SELL
$187.26 - $240.17 $37.1 Million - $47.6 Million
-198,206 Reduced 7.45%
2,462,183 $591 Million
Q1 2023

May 15, 2023
SELL
$174.31 - $239.52 $6.23 Million - $8.56 Million
-35,757 Reduced 1.33%
2,660,389 $500 Million
Q4 2022

Feb 10, 2023
SELL
$153.06 - $226.57 $11.7 Million - $17.3 Million
-76,507 Reduced 2.76%
2,696,146 $573 Million
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $32.6 Million - $41 Million
-224,399 Reduced 7.49%
2,772,653 $436 Million
Q2 2022

Aug 12, 2022
SELL
$130.2 - $168.03 $17.1 Million - $22 Million
-131,169 Reduced 4.19%
2,997,052 $449 Million
Q1 2022

May 13, 2022
SELL
$138.87 - $214.31 $5.69 Million - $8.79 Million
-40,998 Reduced 1.29%
3,128,221 $512 Million
Q4 2021

Feb 14, 2022
BUY
$182.74 - $227.9 $393,621 - $490,896
2,154 Added 0.07%
3,169,219 $690 Million
Q3 2021

Nov 12, 2021
SELL
$170.18 - $198.21 $10.3 Million - $12 Million
-60,738 Reduced 1.88%
3,167,065 $599 Million
Q2 2021

Aug 13, 2021
BUY
$158.62 - $194.3 $512 Million - $627 Million
3,227,803 New
3,227,803 $570 Million

Others Institutions Holding MEDP

# of Institutions
733
Shares Held
24.8M
Call Options Held
104K
Put Options Held
187K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $18.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email